Literature DB >> 12885687

Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data.

Kenneth T Horlander1, David M Mannino, Kenneth V Leeper.   

Abstract

BACKGROUND: Pulmonary thromboembolism (PTE) is a common clinical problem that is associated with substantial morbidity and mortality. Estimates of PTE mortality and predictions of PTE trends have varied widely. These estimates play a role in the planning of national health strategies. The analysis of pulmonary embolism mortality trends and comorbidities may elucidate how well we treat and prevent the disease as well as identify additional risk factors.
METHODS: We analyzed PTE (International Classification of Diseases, Ninth Revision code 415.1) as reported on death certificates in the Multiple-Cause Mortality Files compiled by the National Center for Health Statistics from 1979 to 1998.
RESULTS: Of all the 42932973 decedents, 572773 (1.3%) had PTE listed on their death certificates and 194389 of these (33.9%) had PTE as the underlying cause of death. The age-adjusted rate of deaths with PTE decreased from 191 per million in 1979 to 94 per million in 1998 overall, decreasing 56% for men and 46% for women. During the study period, the age-adjusted mortality rates for blacks were consistently 50% higher than those for whites, and those for whites were 50% higher than those for people of other races (Asian, American Indian, etc). Within racial strata, mortality rates were consistently 20% to 30% higher among men than among women. Conditions that were of higher likelihood in persons who died with PTE included thrombophlebitis, fractures, trauma, postoperative complications, certain cancers, and the inflammatory bowel diseases.
CONCLUSIONS: Mortality with PTE in the United States has decreased during the 20-year period. The mortality rates between men and women and between racial groups vary substantially. These findings may be useful in better directing preventive therapy efforts.

Entities:  

Mesh:

Year:  2003        PMID: 12885687     DOI: 10.1001/archinte.163.14.1711

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  131 in total

1.  Prevention of venous thromboembolic disease in medical and surgical hospital patients in a single university teaching hospital.

Authors:  M B O'Connor; O Pokrovskaya; M Burns; M Weston; S Salleh; L Razak; M I Aiman; F Lainis; M N Shuilleabhain
Journal:  Ir J Med Sci       Date:  2010-09-25       Impact factor: 1.568

2.  Prescription of enoxaparin is associated with decreasing pulmonary embolism mortality rate in Germany.

Authors:  Carolin Pütter; Olga von Beckerath; Hanna Maria Sobik; Holger Reinecke; Jürgen Stausberg; Knut Kröger
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

3.  Imaging thromboembolism with fibrin-avid 99mTc-peptide: evaluation in swine.

Authors:  Mohan R Aruva; Judy Daviau; Shubh S Sharma; Mathew L Thakur
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

Review 4.  [Pulmonary embolism: clinical relevance, requirements for diagnostic and therapeutic strategies].

Authors:  F G Nowak; P Halbfass; E Hoffmann
Journal:  Radiologe       Date:  2007-08       Impact factor: 0.635

5.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 6.  Advances in the diagnosis of venous thromboembolism.

Authors:  Philip S Wells
Journal:  J Thromb Thrombolysis       Date:  2006-02       Impact factor: 2.300

7.  Venous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional database.

Authors:  Brian J Jordan; Richard S Matulewicz; Brian Trihn; Shilajit Kundu
Journal:  World J Urol       Date:  2017-05-17       Impact factor: 4.226

Review 8.  Venous thromboembolism prophylaxis.

Authors:  Jonathan Laryea; Bradley Champagne
Journal:  Clin Colon Rectal Surg       Date:  2013-09

9.  Racial differences in 30-day mortality for pulmonary embolism.

Authors:  Said A Ibrahim; Roslyn A Stone; D Scott Obrosky; Jennifer Sartorius; Michael J Fine; Drahomir Aujesky
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

10.  The SNPs (-1654C/T, -1641A/G and -1476A/T) of protein C promoter are associated with susceptibility to pulmonary thromboembolism in a Chinese population.

Authors:  Changtai Zhu; Ting Jiang; Yafang Miao; Sugang Gong; Kebin Cheng; Jian Guo; Xiaoyue Tan; Jun Yue; Jinming Liu
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.